Invention Grant
- Patent Title: Quinazolinone derivatives useful as vanilloid antagonists
- Patent Title (中): 喹唑啉酮衍生物可用作香草素拮抗剂
-
Application No.: US13089943Application Date: 2011-04-19
-
Publication No.: US08211902B2Publication Date: 2012-07-03
- Inventor: Timothy John Ritchie , Andrew James Culshaw , Christopher Thomas Brain , Edward Karol Dziadulewicz , Terance William Hart
- Applicant: Timothy John Ritchie , Andrew James Culshaw , Christopher Thomas Brain , Edward Karol Dziadulewicz , Terance William Hart
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Strain & Strain PLLC
- Agent Paul D. Strain, Esq.
- Priority: GB0412769.2 20040608
- Main IPC: A61K31/517
- IPC: A61K31/517
Abstract:
The present invention relates to the use of a quinazolinone compound of the formula (I) wherein R1, R2, R3, R4, R5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form, as a vanilloid.
Public/Granted literature
- US20110195983A1 QUINAZOLINONE DERIVATIVES USEFUL AS VANILLOID ANTAGONISTS Public/Granted day:2011-08-11
Information query
IPC分类:
